Danielsgb
Well-Known Member
Here is what I sent them.
Dear Senator XXX,
I want to call for the re-classification of Cannabis from Schedule I to Schedule II. The proper study can show the validity of Medical Marijuana.
I was diagnosed with Multiple Sclerosis in December of 2009. There is valid research showing its ability to slow the progression of MS. Im being denied a drug with no known overdose level because Universities and Doctors cant do research.
I would like to see my Senators support this. Why does the US Government hold the patent for the Medical uses of Cannabinoids? It is US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants.
So they claim it has no medical value then why does the Department of Health and Human Services hold this patent?
Please let me know how we can work together to help the thousands of us with serious medical issues. I added some summary medical information to show what can be learned if doctors can begin research.
Daniels
From Jay R. Cavanaugh, PhD
MS patients have not been well served in the United States by either their government or MS Foundations and Societies. Other nations unencumbered by the cultural baggage of the Drug War have moved ahead to develop cannabis medicines to help relieve the suffering of multiple sclerosis. Hopefully, science and reason will prevail and patients suffering from MS will soon be able to legally grow or receive medicines that will markedly improve both their condition and prognosis.
Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis.
Killestein J, Hoogervorst EL, Reif M, Blauw B, Smits M, Uitdehaag BM, Nagelkerken L, Polman CH.
Department of Neurology, VU Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. [email protected]
Abstract
Cannabinoids can modulate the function of immune cells. We here present the first human in vivo study measuring immune function in 16 MS patients treated with oral cannabinoids. A modest increase of TNF-alpha in LPS-stimulated whole blood was found during cannabis plant-extract treatment (p=0.037), with no change in other cytokines. In the subgroup of patients with high adverse event scores, we found an increase in plasma IL-12p40 (p=0.002). The results suggest pro-inflammatory disease-modifying potential of cannabinoids in MS.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12667658&dopt=Abstract
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ, Nurmikko TJ, Young CA.
Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom. [email protected]
CONCLUSIONS: THC/CBD was effective, with no evidence of tolerance, in these select patients with CNP and MS who completed approximately 2 years of treatment (n = 2
. Ninety-two percent of patients experienced an AE, the most common of which were dizziness and nausea. The majority of AEs were deemed to be of mild to moderate severity by the investigators.
http://www.ncbi.nlm.nih.gov/pubmed/18035205?dopt=Abstract
Marijuana derivatives may provide MS treatment
Dr. J. P. Zajicek, from Peninsula Medical School in Plymouth and colleagues previously reported that cannabinoids taken for 14 weeks appeared to improve mobility and patients perception of their MS symptoms. In an extension study, 80 percent of subjects agreed to continue on the medication for up to 52 weeks. The results are reported in the Journal of Neurology, Neurosurgery and Psychiatry.
http://www.health.am/ab/more/marijuana_derivatives_may_provide_ms_treatment/
Cannabis could hold the key to ending multiple sclerosis misery
April 2, 2007
Researchers investigating the role of cannabinoids - chemical substances contained within cannabis in the treatment of multiple sclerosis (MS), have found they could significantly enhance therapy, not only by reducing nerve damage and erratic nerve impulses, but perhaps even by hindering development of the condition.
http://www.physorg.com/news94743932.html
Slow multiple sclerosis progression with cannabinoids
05/24/10
08:20:26 pm, by Legislative Reporter 
, 610 words
Categories: Patients, Endocannabinoid Research, Multiple Sclerosis (MS)
Slow multiple sclerosis progression with cannabinoids
A $1.5 million National Institutes of Health grant will help Temple University researchers study more effective ways to treat multiple sclerosis (MS). The research uses synthetic (man-made) cannabinoids based on chemicals obtained from the marijuana plant. "MS is a terrible disease and the more rapidly it progresses, the sooner it disables its victims," says co-researcher Doina Ganea, Earle H. Spaulding chair and professor of microbiology and immunology. "So, if you can slow that down for 10 or 20 years, you can make a significant impact on the patients' lives." "These cannabinoids hold enormous potential, and that's encouraging since we're limited in options when it comes to preventing or reversing MS."
Link: http://www.examiner.com/x-32750-Lima-Multiple-Sclerosis-Examiner~y2010m5d24-Slow-multiple-sclerosis-progression-with-cannabinoids
Dear Senator XXX,
I want to call for the re-classification of Cannabis from Schedule I to Schedule II. The proper study can show the validity of Medical Marijuana.
I was diagnosed with Multiple Sclerosis in December of 2009. There is valid research showing its ability to slow the progression of MS. Im being denied a drug with no known overdose level because Universities and Doctors cant do research.
I would like to see my Senators support this. Why does the US Government hold the patent for the Medical uses of Cannabinoids? It is US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants.
So they claim it has no medical value then why does the Department of Health and Human Services hold this patent?
Please let me know how we can work together to help the thousands of us with serious medical issues. I added some summary medical information to show what can be learned if doctors can begin research.
Daniels
From Jay R. Cavanaugh, PhD
MS patients have not been well served in the United States by either their government or MS Foundations and Societies. Other nations unencumbered by the cultural baggage of the Drug War have moved ahead to develop cannabis medicines to help relieve the suffering of multiple sclerosis. Hopefully, science and reason will prevail and patients suffering from MS will soon be able to legally grow or receive medicines that will markedly improve both their condition and prognosis.
Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis.
Killestein J, Hoogervorst EL, Reif M, Blauw B, Smits M, Uitdehaag BM, Nagelkerken L, Polman CH.
Department of Neurology, VU Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. [email protected]
Abstract
Cannabinoids can modulate the function of immune cells. We here present the first human in vivo study measuring immune function in 16 MS patients treated with oral cannabinoids. A modest increase of TNF-alpha in LPS-stimulated whole blood was found during cannabis plant-extract treatment (p=0.037), with no change in other cytokines. In the subgroup of patients with high adverse event scores, we found an increase in plasma IL-12p40 (p=0.002). The results suggest pro-inflammatory disease-modifying potential of cannabinoids in MS.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12667658&dopt=Abstract
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ, Nurmikko TJ, Young CA.
Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom. [email protected]
CONCLUSIONS: THC/CBD was effective, with no evidence of tolerance, in these select patients with CNP and MS who completed approximately 2 years of treatment (n = 2
. Ninety-two percent of patients experienced an AE, the most common of which were dizziness and nausea. The majority of AEs were deemed to be of mild to moderate severity by the investigators.http://www.ncbi.nlm.nih.gov/pubmed/18035205?dopt=Abstract
Marijuana derivatives may provide MS treatment
Dr. J. P. Zajicek, from Peninsula Medical School in Plymouth and colleagues previously reported that cannabinoids taken for 14 weeks appeared to improve mobility and patients perception of their MS symptoms. In an extension study, 80 percent of subjects agreed to continue on the medication for up to 52 weeks. The results are reported in the Journal of Neurology, Neurosurgery and Psychiatry.
http://www.health.am/ab/more/marijuana_derivatives_may_provide_ms_treatment/
Cannabis could hold the key to ending multiple sclerosis misery
April 2, 2007
Researchers investigating the role of cannabinoids - chemical substances contained within cannabis in the treatment of multiple sclerosis (MS), have found they could significantly enhance therapy, not only by reducing nerve damage and erratic nerve impulses, but perhaps even by hindering development of the condition.
http://www.physorg.com/news94743932.html
Slow multiple sclerosis progression with cannabinoids
05/24/10
08:20:26 pm, by Legislative Reporter , 610 words
Categories: Patients, Endocannabinoid Research, Multiple Sclerosis (MS)
Slow multiple sclerosis progression with cannabinoids
A $1.5 million National Institutes of Health grant will help Temple University researchers study more effective ways to treat multiple sclerosis (MS). The research uses synthetic (man-made) cannabinoids based on chemicals obtained from the marijuana plant. "MS is a terrible disease and the more rapidly it progresses, the sooner it disables its victims," says co-researcher Doina Ganea, Earle H. Spaulding chair and professor of microbiology and immunology. "So, if you can slow that down for 10 or 20 years, you can make a significant impact on the patients' lives." "These cannabinoids hold enormous potential, and that's encouraging since we're limited in options when it comes to preventing or reversing MS."
Link: http://www.examiner.com/x-32750-Lima-Multiple-Sclerosis-Examiner~y2010m5d24-Slow-multiple-sclerosis-progression-with-cannabinoids
how the classes going?
The first one was cool, beginning was slow of course. It was mostly about soil types. Cool way to determine what your soil is. Take several samples into a bucket. Mix well, then fill 1/3 to 1/2 a Mason jar. Add a bit of detergent and water to the top. Shake well then let sit for a day. Then measure the layers. The % of Silt, Sand & Clay in this triangle will tell you which yours is. Kinda cool huh?
I hate when that shit happens, and I always try to prevent it but it sure does piss you off 
so about how much water you add? I assume your on the stove top, so how hot at first before the simmer? thanks for the reply!! 
I lower the heat after 10 min. then stir occasionally for 5 to 10 min. The water I mentioned is from the leaves, sry.
